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Abstract
Background
There are very limited data on children with pneumonia in Mali. The objective was to assess
the etiology and factors associated with community-acquired pneumonia in hospitalized
children <5 years of age in Mali.
Methods
A prospective hospital-based case-control study was implemented in the Pediatric depart-
ment of Gabriel Touré University Hospital at Bamako, Mali, between July 2011-December
2012. Cases were children with radiologically-confirmed pneumonia; Controls were hospi-
talized children without respiratory features, matched for age and period. Respiratory speci-
mens, were collected to identify 19 viruses and 5 bacteria. Whole blood was collected from
cases only. Factors associated with pneumonia were assessed by multivariate logistic
regression.
Results
Overall, 118 cases and 98 controls were analyzed; 44.1% were female, median age was
11 months. Among pneumonia cases, 30.5% were hypoxemic at admission, mortality was
4.2%. Pneumonia cases differed from the controls regarding clinical signs and symptoms
but not in terms of past medical history. Multivariate analysis of nasal swab findings dis-
closed that S. pneumoniae (adjusted odds ratio [aOR] = 3.4, 95% confidence interval [95%
CI]: 1.6–7.0), human metapneumovirus (aOR = 17.2, 95% CI: 2.0–151.4), respiratory syn-
cytial virus [RSV] (aOR = 7.4, 95% CI: 2.3–23.3), and influenza A virus (aOR = 10.7, 95%
CI: 1.0–112.2) were associated with pneumonia, independently of patient age, gender,
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period, and other pathogens. Distribution of S. pneumoniae and RSV differed by season
with higher rates of S. pneumoniae in January-June and of RSV in July-September. Pneu-
mococcal serotypes 1 and 5 were more frequent in pneumonia cases than in the controls (P
= 0.009, and P = 0.04, respectively).
Conclusions
In this non-PCV population from Mali, pneumonia in children was mainly attributed to S.
pneumoniae, RSV, human metapneumovirus, and influenza A virus. Increased pneumo-
coccal conjugate vaccine coverage in children could significantly reduce the burden of
pneumonia in sub-Saharan African countries.
Introduction
Pneumonia is the leading cause of child mortality from infectious diseases, accounting for an
estimated 1 million deaths annually, and mainly affecting children in developing countries
[1,2]. Mortality attributed to pneumonia has decreased since 2000, but remains a major public
health concern [3,4]. The main known causative pathogens reported are Streptococcus pneumo-
niae,Haemophilus influenzae type B, and respiratory syncytial virus (RSV) [5]. However, their
distribution varies by season and location. Data on the etiology and epidemiology of pneumo-
nia in children in developing countries are still insufficient, particularly in sub-Saharan Africa
[6].
Mali is one of the poorest countries in the world, with a under-five year mortality rate of
123 per 1,000 live births in 2013 according to the UN Inter-agency Group for Child Mortality
Estimation. It has been estimated that among its 14.9 million inhabitants, each year more than
900,000 pneumonia episodes occur in children under 5 years of age, leading to almost 8,000
deaths annually [7]. A previous descriptive study reported that pneumonia was the most fre-
quent cause of admission, representing 18% of total hospital admissions [8]. However, detailed
information was not available on clinical presentation and on the etiology of suspected pneu-
monia cases [8]. Moreover, no control group was included. The presence of a control group of
children without pneumonia would allow better interpretation of microbiological findings,
particularly with nasal sampling [9]. In March 2011, Mali included pneumococcal vaccination
(PCV13) in a routine immunization program; but vaccine coverage is still low [10].
The study objective was to assess the etiology and factors associated with community-
acquired pneumonia in hospitalized children in Mali.
Materials and Methods
Setting and Participants
A prospective multicenter case-control study, based on the Global Approach to Biological
Research, Infectious diseases and Epidemics in Low-income countries (GABRIEL) network [11],
was implemented in the Pediatric department of Gabriel Touré University Hospital at Bamako,
Mali, between July 2011 and December 2012. This multicenter study is ongoing, it will include
ten study sites, located in 9 countries over 3 continents (Brazil, Cambodia, China, Haiti, India,
Madagascar, Mali, Mongolia, and Paraguay). The study protocol has been described in detail
elsewhere [12], and pooled results will be analyzed later.
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ratio; PCV, pneumococcal conjugate vaccination;
PCT, procalcitonin; RSV, respiratory syncytial virus;
RT-PCR, real-time multiplex polymerase chain
reaction; WHO, World Health Organization.
The Gabriel Touré University Hospital is a 447-bed tertiary-care general hospital located in
Bamako. It is a primary care hospital for people living in Bamako and a national reference cen-
tre for other patients. Various medical and surgical specialities, including pediatrics, are located
in the hospital. The pediatrics department, with a capacity of 150 beds, includes a general pedi-
atrics unit and a neonatal/emergency unit. It receives sick children for primary care and severe
cases referred from other healthcare settings. On average, 50,000 consultations and 10,000 hos-
pital admissions occur in the pediatrics department annually. Acute respiratory infections rep-
resent 34% of admissions in children, and 15% of child hospitalizations.
Case Definition and Enrollment
Pneumonia cases were hospitalized children who fulfilled the following criteria:
- Cough and/or dyspnea, and
- Tachypnea, as characterized by the World Health Organization (WHO) in children between
2 and 12 months of age: breathing rate50 cycles per minute; in children between 12 and
59 months of age: breathing rate40 cycles per minute) [13], and
- Absence of wheezing at auscultation, and
- First symptoms appearing within the last 14 days, and
- Radiological confirmation of pneumonia as per WHO guidelines [14].
The exclusion criterions for cases were presence of wheezing at auscultation, or minors
whose parents or legal guardian declined to sign the informed consent statement. Controls
were patients hospitalized for surgery or in a routine outpatient practice environment, aged
between 2 and 59 months, without any symptoms suggestive of respiratory illness; suspicion of
infection of other site was not an exclusion criteria. Cases and controls were matched for age
(±1 year) and calendar date of hospital admission (±1 month) to take seasonality into account.
Thus, 61% of patients were recruited during the rainy season (May to October) while 39% were
recruited during the dry season (November to April).
Biological Samples
Samples were collected in the first 48 hours of patient hospitalization. Nasal swabs were taken
from all pneumonia cases and controls. To document antibiotic usage history, urine was sam-
pled from cases for broad spectrum antibiotic detection. Whole blood and pleural effusions (in
applicable cases) were collected from cases only. Whole blood was distributed in Ethylenedi-
aminetetraacetic acid (EDTA) vials for preservation and in dry tubes for serum specimens.
EDTA-whole blood samples allowed complete blood count, blood culture and real-time multi-
plex polymerase chain reaction (PCR) assay for the identification of Staphylococcus aureus,
Streptococcus pneumoniae and Haemophilus influenzae type b. C reactive protein (CRP) and
procalcitonin (PCT) were measured quantitatively in serum.
Respiratory specimens from nasal swabs and pleural effusions were characterized by FTD
respiratory pathogens 21 plus (Fast-track Diagnostics, Luxembourg) based on RT-PCR which
included a panel of 19 viruses and 5 bacteria. The pathogens identified were: influenza A, influ-
enza A(H1/N1), influenza B, coronavirus 229E, coronavirus OC43, coronavirus NL63, corona-
virus HKU1, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza
virus 4, human metapneumoviruses A and B, rhinovirus, RSVs A and B, adenovirus, enterovi-
rus, parechovirus, bocavirus,Mycoplasma pneumoniae, Chlamydia pneumoniae, S. aureus, S.
pneumoniae, and H. influenzae type b. S. pneumoniae-positive specimens were serotyped by
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RT-PCR that detects the 29 main S. pneumoniae serotypes: 1, 3, 4, 5, 6A/B, 7C, 7F, 8, 9V, 10A,
11A, 12F, 14, 15A, 15B/C, 16F, 17F, Sg18C, 19A, 19F, 20, 22F, 23F, 31, 33F, 34, 35B, 35F, 38
and Lyt A.
Statistical Analysis
Demographic characteristics, underlying diseases, medical history, clinical examination at
enrollment, radiological findings, vaccinations, and outcome were recorded prospectively for
each patient on a standardized form.
Continuous variables were described as median and interquartile range (IQR), categorical
variables as number and percentage. Pneumonia cases we compared to the controls by the
Mann-Whitney U test for continuous covariates, and by the Chi2 test for categorical variables.
Univariate and multivariate logistic regression analyses were performed to assess factors associ-
ated with pneumonia. Multivariate analyses were adjusted for gender, age, period per quarter,
and other pathogens significantly associated with increased risk of pneumonia. Concordance
between serotypes detected in nasopharyngeal samples and blood was tested by Kendall rank
correlation.
Crude population attributable fraction (PAF) was calculated after univariate logistic regres-
sion analysis to quantify the contribution of the each microorganism to pneumonia occur-
rence. Conceptuality, PAF permits the estimation of the proportional reduction in pneumonia
occurrence that would occur if the pathogen was absent (alternative ideal scenario). The for-
mula was the following:
PAF ¼ Prc  ðOR 1Þ
1þ Prc  ðOR 1Þ
With : Prc ¼ Prevalence of microorganim detection in controls; OR ¼ crude odds ratio:
No patient was excluded because of missing data. P<0.05 was considered significant; all
tests were bilateral, and statistical analysis was conducted with Stata version 13.0 (Stata Corp.).
With at least 100 cases and 100 controls, analyses had 80% power to detect odds ratios (OR)3
with20% prevalence of control exposure, whatever the prevalence of case exposure.
Ethics
The study protocol, informed consent statement, clinical research form, any amendments and
all other study documents were submitted to and approved by the institutional ethics commit-
tee (Comité National d'Ethique pour la Santé et les Sciences de la Vie). Written informed con-
sent was obtained from all participants.
Results
Overall Population
Among the 119 enrolled cases, 118 conformed with the inclusion criteria and were all sampled.
One patient without radiological confirmation was excluded from the analysis. Among the 100
included controls, 2 were excluded because of missing data.
Overall, 216 patient, accounting for 118 (54.6%) pneumonia cases and 98 (45.4%) controls,
were analyzed. Among them, 93 (44.1%) were female. The male/female gender ratio was 0.79,
and median age was 11 months (IQR: 5–55 months).
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Description of Pneumonia Cases
Among the 118 patients with pneumonia, 16 (13.6%) were referred from another health center;
median length of hospital stay was 7 days (IQR: 6–10 days) for a total of 909 days of hospitali-
zation (Table 1). The median time period between first symptoms and hospitalization was 6
days (IQR: 4–7 days).
Four (3.9%) pneumonia cases presented a ventricular septal defect. None had previous
tuberculosis or underlying lung disease. Among cases with pulmonary crackles, 36 (35.3%)
were unilateral and 66 (64.7%) were bilateral. Other signs or medical history of pneumonia
cases included sickle-cell anaemia (n = 1), dehydration (n = 1), epilepsy (n = 1), goiter (n = 1),
edema (n = 1), pallor (n = 1), and trisomy (n = 3).
Among the 47 patients who took antibiotics before hospitalization, 17 (14.4%) received
Amoxicillin, 8 (5.6%) Ceftriaxone, 4 (2.8%) Amoxicillin/Clavulanic acid, and 3 (2.1%) Cotri-
moxazole. Among the 63 cases tested for antibiotic detection testing in urine, 22 (65.1%) were
positive; in this population, sensitivity of declared antibiotic use compared with urine detection
was low (sensitivity = 51.2%, 95% confidence interval: 35.1–67.1%).
Median CRP level at admission was 21 mg/l (IQR: 6–63, mean: 56.6 mg/l), median PCT
level was 4.6 ng/ml (IQR: 0.4–26.4, mean: 31.5 ng/ml). Median CRP and PCT levels were
higher in hypoxemic compared with non-hypoxemic pneumonia cases (P = 0.03 and
P = 0.007, respectively).
Median white blood cell count was 15,750109cells/l (IQR: 10,000–25,700, mean:
20,600109cells/l), and median neutrophil percentage was 52.5% (IQR: 31–68, mean: 50.3%).
X-rays showed generalized, dense, homogeneous opacification in 24 (20.3%) patients, intersti-
tial syndrome in 24 (20.5%), and alveolar infiltrate in 65 (55.1%), without significant differ-
ences according to the pattern of infection (viral, bacterial or mixed). No patient had abscess or
pneumothorax, but 4 (3.4%) had pleural effusion.
During hospital stay, pneumonia cases received the following antibiotics: Amoxicillin
(n = 111, 94.1%), Ceftriaxone (n = 3, 2.6%), Amoxicillin/Clavulanic acid (n = 3, 2.5%), Cipro-
floxacin (n = 1, 0.8%), and Vancomycin (n = 2, 1.6%). Fifty-one (43.2%) received oxygen for a
median length of 2 days (IQR: 1–3 days), and 3 (2.5%) had blood transfusions. Three patients
with pleural effusions were tested for microbial detection. Five patients died (lethality: 4.2%);
death was directly related to pneumonia in 4 patients (Table 2).
Comparison of Characteristics of Pneumonia Cases and Controls
Table 1 compares the clinical signs and symptoms at admission between cases and controls,
underlying conditions and biological findings. Pneumonia cases differed from controls regard-
ing clinical signs and symptoms as well as vital signs at admission, but not in terms of demo-
graphic factors or past medical history. Pneumonia cases were more frequently hypoxemic
(defined as oxygen saturation<90%) at admission than the controls (30.5% vs. 0%, P<0.001).
PCV coverage was zero in both groups.
Microbiological Findings
At least 1 microorganism was detected on nasal swabs in 96.6% of cases and 82.3% of controls
(crude OR = 6.4, 95% confidence interval [95% CI]: 2.1–19.7, P<0.001). Overall, 78.8% of
cases and 54.2% of controls were co-infected or co-colonized (crude OR = 3.3, 95% CI: 1.8–6.0,
P<0.001). Co-detection on nasal swab of S. pneumoniae and RSV was more frequent in cases
than in controls (respectively, 15.2% [N = 18] vs. 2.0% [N = 2], P = 0.001). Co-detection of S.
pneumoniae and rhinovirus was not different in cases and controls (respectively, 16.1%
[N = 19] vs. 12.2% [N = 12], P = 0.42; co-detection RSV and rhinovirus was not different
Pneumonia Etiology in Children fromMali
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Table 1. Characteristics of children pneumonia cases and controls, Mali, N = 216.
Characteristicsa Pneumonia cases (n = 118) Controls (n = 98) P
Demographics at admission
Gender, male 57 (48.3) 36 (38.7) 0.16
Age, months, median (IQR) 12 (5–26) 11 (5–23) 0.24
Height, cm, median (IQR) 73.5 (65–88) 71 (64–79) 0.04
Weight, kg, median (IQR) 7.6 (6–10) 7 (5.5–9.3) 0.13
Body mass index, median (IQR) 13.9 (12.6–15.2) 14.2 (12.9–15.5) 0.47
Arm circumference, cm, median (IQR) 13 (12–14) 12.5 (11–14) 0.01
Weight-for-height Z-score 2 SD 52 (44.1) 41 (44.1) 0.99
Weight-for-height Z-score 3 SD 32 (27.1) 22 (23.7) 0.57
Medical history
Heart disease 4 (3.4) 0 (0) 0.07
HIV-positive 3 (2.5) 0 (0) 0.12
Contracted a common cold/pharyngitisb 61 (31.7) 0 (0) <0.001
Contracted ILIb 18 (15.2) 0 (0) <0.001
Pneumococcal conjugate vaccine 0 (0) 0 (0) -
DPT-Hep. B-Hib vaccine, 1 dose 102 (86.4) 80 (86.0) 0.93
DPT-Hep. B-Hib vaccine, 3 dose 81 (68.6) 69 (74.2) 0.38
Inﬂuenza vaccine 1 (0.8) 0 (0) 0.37
Vital signs at admission
Temperature, °C, median (IQR) 38.6 (37.8–39.4) 37 (36.8–37.4) <0.001
Breathing rate, cycles/min, median (IQR) 56 (48–67) 31 (29–35) <0.001
Cardiac rate, cycles/min, median (IQR) 151 (132–167) 122 (112–132) <0.001
Oxygen saturation, %, median (IQR) 94.5 (87–96) 98 (98–99.5) <0.001
Clinical signs/symptoms at admission
Dyspnea 116 (98.3) 0 (0) <0.001
Lower chest indrawing 116 (98.3) 0 (0) <0.001
Cough 114 (96.6) 0 (0) <0.001
Pulmonary crackles 102 (86.4) 0 (0) <0.001
Ronchi 34 (28.8) 0 (0) <0.001
Rhinopharyngitis 32 (27.1) 0 (0) <0.001
Prostration or lethargy 23 (19.5) 0 (0) <0.001
Inability to drink 15 (12.7) 0 (0) <0.001
Diarrhea 12 (10.2) 20 (21.5) 0.02
Cyanosis 11 (9.3) 0 (0) 0.002
Vomiting 9 (7.6) 13 (14.0) 0.13
Convulsions 6 (5.1) 2 (2.1) 0.27
Conjunctivitis 6 (5.1) 1 (1.1) 0.11
Diminished breath sounds 5 (4.2) 0 (0) 0.04
Dullness to percussion 4 (3.4) 0 (0) 0.07
Otitis 3 (2.5) 1 (1.1) 0.44
Rasping 3 (2.5) 0 (0) 0.12
Skin rash 0 (0) 2 (2.1) 0.11
Abbreviations: IQR, interquartile range; SD, standard deviation; DPT-Hep. B-Hib, Diphtheria, tetanus, Pertussis, hepatitis B, Haemophilus inﬂuenza type b;
HIV, human immunodeﬁciency virus; ILI, inﬂuenza-like illness
aData are N (%), unless speciﬁed otherwise.
bwithin 2 weeks.
doi:10.1371/journal.pone.0145447.t001
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between cases and controls (respectively, 5.9% [N = 7] vs. 3.1% [N = 3], P = 0.32). A dose-
response relationship was apparent between the number of microorganisms found in nasal
swabs and the risk of being a case (Fig 1). Distribution of S. pneumoniae and RSV differed by
season with higher rates of S. pneumoniae in January-June and of RSV in July-September
(Fig 2).
Univariate analysis revealed that S. pneumoniae, human metapneumovirus, RSV, and influ-
enza A virus detection in nasal swabs were significantly associated with pneumonia in Mali
(Table 3). Multivariate analysis reinforced linkage of these pathogens with pneumonia, inde-
pendently of patient age, gender, period per quarter and the presence of other pathogens signif-
icantly coupled with increased risk of pneumonia (Table 3). PAF was the highest for S.
pneumoniae (PAF = 46%, 95% CI: 30–59%). Contribution of human metapneumovirus, RSV,
and influenza A were lower, with PAFs of 9% (95% CI: 7–11%), 21% (95% CI: 16–25%) and,
8% (95% CI: 6–10%), respectively.
Fig 3 reports the distribution of pneumococcal serotypes detected in nasal swabs from cases
and controls. The most prevalent serotype in pneumonia cases and controls was serotype 6A/B
(18.6% vs. 11.2%, P = 0.13). Serotypes 1 and 5 were more frequent in pneumonia cases than in
the controls: 6.8% vs. 0%, P = 0.009, and 4.2% vs. 0%, P = 0.04, respectively.
In pneumonia cases, S. pneumoniae was positive in 16 (13.6%) patients, S. aureus in 6
(5.1%) patients and H. influenza in 5 (4.2%) patients by PCR blood sample detection. Most
Fig 1. Relative risk (95% confidence interval) of pneumonia in children according to number of microorganisms from nasal swab, Mali, N = 216.
aAfter multivariate logistic regression, adjusted for gender, age, and period per quarter. bLogarithmic scale.
doi:10.1371/journal.pone.0145447.g001
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patients with S. pneumoniae detection by PCR had also S. pneumoniae nasal carriage (93.5%,
15/16), while only 17.6% (15/85) of patients with S. pneumoniae nasal carriage had positive
detection by PCR (P = 0.04). Concordance of serotype 1 detected in nasal swabs and blood in
pneumonia cases was high (κ = 0.70, P<0.001). Coronavirus 63 was identified from pleural
effusion in 1 patient. Microbiological findings, including S. pneumoniae serotypes distribution,
from PCR nasal swab or blood sample were not different in pneumonia cases according to the
result of urine antibiotic testing (data not shown). Blood culture was positive in 36 (30.5%)
pneumonia cases; most microorganisms were probably related to contamination of samples.
The following bacteria were detected: coagulase-negative staphyloccoci (n = 26), Salmonella
spp. (n = 3), Gram-positive bacilli (n = 2), Acinetobacter baumannii (n = 1), Aerococcus viri-
dans (n = 1), Enterococcus faecium (n = 1), Granulicatella elegans (n = 1), and Staphylococcus
aureus (n = 1).
Discussion
The primary objective of this prospective case-control study was to assess the etiology and fac-
tors associated with community-acquired pneumonia in hospitalized children in Mali. In this
non-PCV population, we observed that S. pneumoniae, human metapneumovirus, RSV, and
influenza A were the main microbial agents associated with pneumonia among children in
Mali, independently of patient age, gender, period, and other pathogens. H. influenzae was not
Fig 2. Temporal trends of pneumonia etiology in childhood cases, Mali, N = 118. *P < .05, **P < .001.
doi:10.1371/journal.pone.0145447.g002
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associated with pneumonia, but the vaccination rate against this bacteria, at least for the first
dose, was above 85% in both cases and controls. In addition, while most patients with S. pneu-
moniae by PCR in blood had also nasal carriage, frequently with the same serotype, positive S.
pneumoniae test from nasal sample was not highly predictive of S. pneumoniae detection in
blood, meaning that the bacteria was frequently not the cause of pneumonia.
Few studies have assessed the etiology of pneumonia in sub-Saharan Africa. Howie et al.
recently investigated pneumonia etiology in children in Gambia, observing that S. pneumoniae
was the leading cause with a high rate of microbial agent co-detection [15]. Conversely, they
found that viral pneumonia was not predominant whereas we observed that 3 viruses, namely
human metapneumovirus, RSV, and influenza A virus, were associated with pneumonia in
Mali. Major differences between the 2 studies were sample type (lung aspirates vs. nasal swabs
Table 3. Microbiological findings of children pneumonia cases and controls, nasal swabs, Mali,
N = 216.
Microorganisms Pneumonia
cases (n = 118)
Controls
(n = 98)
P Crude odds
ratio (95% CI)
Adjusted odds
ratioa (95% CI)
Bacteria
Streptococcus
pneumoniae
85 (72.0) 47 (48.0) <0.001 2.8 (1.6–4.9) 3.4 (1.6–7.0)
Staphylococcus
aureus
23 (19.5) 19 (19.4) 0.98 1.0 (0.5–2.0) -
Haemophilus
inﬂuenza
8 (6.8) 6 (6.2) 0.84 1.1 (0.4–3.3) -
Mycoplasma spp. 0 (0) 1 (1.0) 0.27 NE -
Chlamydia spp. 0 (0) 0 (0) - NE -
Viruses
Human
metapneumovirus
12 (10.2) 1 (1.0) 0.005 11.0 (1.4–
86.0)
17.2 (2.0–151.4)
Coronavirus NL63 1 (0.8) 4 (4.1) 0.12 0.2 (0.02–1.8) -
Coronavirus 229E 2 (1.7) 0 (0) 0.19 NE -
Coronavirus OC43 2 (1.7) 4 (4.1) 0.29 0.4 (0.07–2.3) -
Coronavirus HKU 1 6 (5.1) 2 (2.0) 0.24 2.6 (0.5–13.0) -
Adenovirus 11 (9.3) 6 (6.1) 0.39 1.6 (0.6–4.4) -
Enterovirus 12 (10.2) 14 (14.3) 0.35 0.7 (0.3–1.5) -
Parechovirus 0 (0) 0 (0) - NE -
Rhinovirus 27 (22.9) 24 (24.5) 0.78 0.9 (0.5–1.7) -
Respiratory syncytial
virus
30 (25.4) 6 (6.1) <0.001 5.2 (2.1–13.2) 7.4 (2.3–23.3)
Parainﬂuenzae 1 5 (4.2) 0 (0) 0.04 NE -
Parainﬂuenzae 2 1 (0.8) 0 (0) 0.36 NE -
Parainﬂuenzae 3 5 (4.2) 3 (3.1) 0.65 2.0 (0.4–10.6) -
Parainﬂuenzae 4 2 (1.7) 4 (4.1) 0.29 0.4 (0.07–2.1) -
Inﬂuenza A 11 (9.3) 1 (1.0) 0.008 10.0 (1.3–
78.7)
10.7 (1.0–112.2)
Infuenza B 0 (0) 0 (0) - NE -
Inﬂuenza A(H1N1) 3 (2.5) 0 (0) 0.11 NE -
Bocavirus 13 (11.0) 12 (12.2) 0.78 0.9 (0.4–2.0) -
Abbreviations: NE, non estimable.
a After multivariate logistic regression, adjusted for the presence of other pathogens, gender, age, and
period per quarter.
doi:10.1371/journal.pone.0145447.t003
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in our investigation) and the lack of a comparative group in the study by Howie et al. which
did not permit comparison of microbial prevalence in pneumonia patients and healthy subjects
[15]. In a Western Kenya case-control study, S. pneumoniae, RSV, and influenza A virus were
the predominant causes of pneumonia in children [16]. We noted almost similar results in
Mali. Thus, S. pneumoniae and RSV could still be considered as the primary causes of pneumo-
nia in several sub-Sharan African countries.
All patients who died had severe pneumonia, according to WHO criteria, with significant
dyspnea, very marked chest indrawing and severe hypoxia. Two patients had confirmed pneu-
mococcal pneumonia. Two patients had acute malnutrition linked with pneumonia. In 2 cases,
death occurred within 24 hours of admission. Despite active treatment with antibiotics and
oxygen, the management of severe respiratory distress is often difficult in this context because
the hospital does not have assisted ventilatory support. Mortality was higher than in a recent
birth cohort in South Africa [17], but was similar to what was reported previously in other
developing countries [18,19].
Some invasive serotypes were detected selectively in pneumonia cases but not in the controls
(i.e., serotypes 1 and 5 were associated with the risk of pneumonia). A previous study of sero-
types involved in invasive pneumococcal disease in Mali found that serotype 5 was the most
prevalent (54%) [20]. It was also linked with pneumonia in our series. In other sub-Saharan
African countries, serotype 1 was described as the most prevalent serotype of invasive pneumo-
coccal disease [21]. It was the second serotype significantly associated with pneumonia in chil-
dren in Mali. Thus, the introduction of PCV in routine immunization programs in Mali would
substantially reduce pneumonia caused by S. pneumoniae because most serotypes eliciting
pneumonia would be covered by the vaccine [22]. In addition, pneumococcal pneumonia sea-
sonality was similar to that observed previously in Burkina Faso, a neighbouring country, in
2007–2011 with higher incidence during the dry season between January and May [23].
Fig 3. Streptococcus pneumoniae serotypes in nasal aspirates from pneumonia cases and controls, Mali, N = 216. *P < .05, **P < .001.
doi:10.1371/journal.pone.0145447.g003
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Interestingly, among the 4 microbial agents associated with pneumonia, 3 were viruses:
human metapneumovirus, RSV, and influenza A virus. Self et al. recently observed, in a pneu-
monia cases-control study implemented in hospitals of Utah, that detection respiratory syncy-
tial virus, human metapneumovirus and influenza from nasopharyngeal or oropharyngeal
sample of patients with pneumonia probably indicates an etiologic role [24].
We observed similar results in a different context. Despite the dearth of vaccination against
pneumococcus in our population, viral pneumonia is a major segment of the pneumonia bur-
den. Treatment of these infections is often problematic because the empirical use of antibiotics
or antivirals is not consensual [25]. Vaccine development, particularly against RSV, is war-
ranted to prevent pneumonia in children. Moreover, the impact of influenza vaccine policies in
developing countries should be evaluated because this virus often causes pneumonia [26].
Rhinovirus was detected in almost 25% of pneumonia cases of our series, but the detection
rate was not different between cases and controls. However, this observation does formally
excludes that rhinovirus could play a role in the etiology of pneumonia. Jain et al. recently
observed that rhinovirus was detected in 27% of U.S. children with community-pneumonia
requiring hospitalization [27]; this large study had however no control group, it was also not
possible to estimate the prevalence of respiratory detection in children without pneumonia.
Growing evidence suggests the role of rhinovirus in the etiology of viral pneumonia [28] or
related to the risk of secondary bacterial pneumonia [29]. Other viruses, such as bocavirus or
adenovirus were also equally prevalent in cases and controls. Again, this finding does not
exclude completely their implication in pneumonia etiology in children fromMali. However
these viruses were poorly described as causative agents of pneumonia in children from other
sub-Saharan African countries.
Several microorganisms have been detected in most pneumonia cases but also in the con-
trols. The clinical significance of microbial detection by PCR is problematic at the individual
level because most detected pathogens are not causes of pneumonia. However, number of path-
ogens is predictive of the risk of pneumonia, suggesting that simple quantification of species
detected would permit the evaluation of pneumonia risk. At the population level, nasal samples
are interesting because the prevalence of carriage in the controls is considered.
The main strengths of our study were its prospective design with the inclusion of controls
that permitted us to assess pneumonia etiologies while taking into account the prevalence of
pathogen detection in non-infected patients. Ours is the first case-control investigation of
pneumonia etiology in children fromMali (S1 STROBE checklist). The results should serve to
better manage pneumonia not only in these children but also in those from neighboring coun-
tries. Data quality was enhanced by centralized microbiological analysis in the Emerging Path-
ogens Laboratory (Lyon, France). In addition, this analysis should serve to better focus
multicentric pneumonia studies that will permit us to assess the global etiologies of pneumonia
and to compare etiologic agents between countries and continents.
Some limitations should be underlined. First, microbiological diagnosis of pneumonia is dif-
ficult due to the lack of single reliable test. Then, at the individual level, it is difficult to establish
if a positive nasal swab denotes etiology or nasopharyngeal colonization; particularly for bacte-
rial agents such as S. pneumoniae because of the high asymptomatic carriage. However, at the
population level, addition of a control group permits to evaluate and control for the prevalence
of carriage in asymptomatic children. In a pneumonia etiology study, it would be interesting to
correlate the threshold cycle (Ct) values obtained from RT-PCR with lower airway specimens
to establish more precisely the relationship between positive nasal swab and etiology of pneu-
monia, according to the microorganism [30]. Second, because the study was implemented in
one hospital in Mali, external validity might be limited. However, Gabriel Touré University
Hospital is a reference center in the country, and then source population is not limited to the
Pneumonia Etiology in Children fromMali
PLOS ONE | DOI:10.1371/journal.pone.0145447 December 22, 2015 12 / 15
city of Bamako. Third, study power was confined to detecting some linkages (i.e. serotypes
associated with the risk of pneumonia).
Conclusion
Community-acquired pneumonia was mainly attributable to S. pneumoniae, human metap-
neumovirus, RSV or influenza A among children in Mali. Increased pneumococcal conjugate
vaccine coverage in children would significantly reduce the burden of pneumonia in this coun-
try. The addition of a control group to assess etiologies of pneumonia in children is critical to
properly interpret the microbiological results of diagnostic testing with high sensitivity.
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